Our exploratory work may serve as a pilot for future studies that use unsupervised analysis of CD34+ cells in MDS patients stratified by death cause in combination with functional and molecular analysis of the identified populations of interest. The gene discussed is CD34; the disease is myelodysplastic syndrome.